Point72 (DIFC)’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,950
Closed -$82.1K 948
2024
Q4
$82.1K Buy
2,950
+2,142
+265% +$59.6K ﹤0.01% 501
2024
Q3
$23.2K Buy
+808
New +$23.2K ﹤0.01% 681